http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2310425-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
| filingDate | 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc29d807999b27a4749ec5cd1fb021a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06dddf474ff59c77ee13472016baec94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff9457f6111c6ee81b1aa072560bc2a |
| publicationDate | 2007-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2310425-C1 |
| titleOfInvention | Method for treating a progressing form of myopia |
| abstract | FIELD: medicine, ophthalmology. n SUBSTANCE: it is necessary to carry out structural-resonance electromagnetic therapy upon "REMATERP" device for the period of 43 min in scanning mode N43, 10 procedures/course at a 2-d-long interval during 1 mo. Simultaneously, it is necessary to fulfill antioxidant therapy with preparation "Vitrum Vision" per 1 tablet twice daily for 1 mo. The suggested innovation enables to decrease the percentage of disease progressing nature, decrease the quantity of complicated forms and the percentage of surgical interferences. n EFFECT: higher efficiency of therapy. n 2 tbl |
| priorityDate | 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.